THE DEAL, AT A GLANCE
From the announcementSoley Therapeutics
01Who is involvedBacked by GordonMD Global InvestmentsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedSoley Therapeutics raised $200M Series C, announced 2026-01-07From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersSoley Therapeutics is using a $200M Series C to move its lead AML asset toward an IND filing while expanding a cell stress sensing drug discovery platform across…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Soley Therapeutics · Financing Record
Explore source-linked visual explanations for Soley Therapeutics. Unsupported claims are withheld while source review continues.
Record 3452 · Recorded date: 2026-01-07
Explore company records →